Article head image with title and company name
10 March 2026
Precision medicine: Recent advances in targeted therapies for solid tumour treatment

  Over 90% of newly diagnosed cancers are solid tumours, which includes those with the highest mortality rates such as breast, lung, colorectal and prostate cancer [1,2]. Surgical resection and chemotherapy, once the backbone of solid tumour management, are increasingly limited by poor target specificity, chemotherapy resistance and tumour recurrence [3,4]. These traditional treatment strategies …

Continue reading “Precision medicine: Recent advances in targeted therapies for solid tumour treatment”